Network pharmacological analysis of dyssomnias and Litsea pungens Hemsl.
Integrate Medicine · 31.12.2025
DOI: 10.61958/imwa5181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.12.2025. Verfasst von Qi Liao und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Background
Insomnia, characterized by difficulties in sleep-onset , maintenance, and poor sleep quality, exerts substantial adverse effects on immune function, cognitive abilities, and mental health. Current treatments face limitations such as drug dependence and poor compliance, highlighting the need for safe and effective alternatives. Litsea pungens Hemsl., a traditional medicinal plant with anti-inflammatory, antioxidant, and sedative properties, shows potential for improving sleep disorders, but its underlying mechanisms remain insufficiently elucidated.
Methods
A network pharmacology approach was employed to systematically explore the anti-dyssomnias mechanisms of Litsea pungens Hemsl. Relevant targets of dyssomnias and Litsea pungens Hemsl. were retrieved from public databases (GeneCards, ETCM2.0, etc.), and overlapping targets were identified using Venny analysis. Protein-protein interaction (PPI) networks were constructed via STRING and Cytoscape to screen core hub genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted. In addition, a "symptom-site-key target-KEGG pathway" network was established.
Results
A total of 789 dyssomnias-related targets and 38 Litsea pungens Hemsl.-related targets were identified, with 15 overlapping targets. PPI analysis revealed 10 core hub genes, including HTR2C, SLC6A3, DRD2, SLC6A4, HTR3A, DRD4, HTR1B, SLC6A2, ADRB2, and ADRB1. GO enrichment analysis indicated that these targets participate in biological processes such as adenylate cyclase–activating adrenergic receptor signaling and dopamine uptake, are mainly localized to synapses and plasma membranes, and are associated with molecular functions including neurotransmitter transport and G protein–coupled receptor activity. KEGG analysis showed significant enrichment in pathways related to neuroactive ligand–receptor interaction, cAMP signaling, and serotonergic and dopaminergic synapses.
Conclusions
Litsea pungens Hemsl. may exert anti-insomnia effects through multi-target and multi-pathway modulation, primarily involving neurotransmitter-related targets (SLC6A4, DRD2) and key pathways such as neuroactive ligand–receptor interaction and cAMP signaling. These findings provide a theoretical basis for further preclinical and clinical evaluation of Litsea pungens Hemsl. as a natural agent for insomnia management.
Zitieren
APA
Liao, Q., Si, J., Hu, J., You, K., Wang, T., & Zhang, X. (2025). Network pharmacological analysis of dyssomnias and Litsea pungens Hemsl. Integrate Medicine. https://doi.org/10.61958/imwa5181
Vancouver
Liao Q, Si J, Hu J, You K, Wang T, Zhang X. Network pharmacological analysis of dyssomnias and Litsea pungens Hemsl. Integrate Medicine. 2025. doi:10.61958/imwa5181
BibTeX
@article{Liao2025,
author = {Liao, Qi and Si, Jun and Hu, Jun-Jie and You, Ke and Wang, Ting-Hua and Zhang, Xiao},
title = {Network pharmacological analysis of dyssomnias and Litsea pungens Hemsl},
journal = {Integrate Medicine},
year = {2025},
doi = {10.61958/imwa5181}
}
EUVIMED